Research output per year
Research output per year
Research output
- 10 results
Search results
-
2018
Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group
Perego, P., Hempel, G., Linder, S., Bradshaw, T. D., Larsen, A. K., Peters, G. J. & Phillips, R. M., 1 Mar 2018, In: Cancer Chemotherapy and Pharmacology. 81, 3, p. 427-441 15 p.Research output: Contribution to journal › Review article › peer-review
Open AccessFile11 Citations (Scopus) -
2016
Cannabinoid pharmacology in cancer research: A new hope for cancer patients?
Javid, F. A., Phillips, R. M., Afshinjavid, S., Verde, R. & Ligresti, A., 15 Mar 2016, In: European Journal of Pharmacology. 775, p. 1-14 14 p.Research output: Contribution to journal › Review article › peer-review
46 Citations (Scopus) -
Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs Cytotoxic Reviews Godefridus J. Peters and Eric Raymond
Phillips, R. M., 1 Mar 2016, In: Cancer Chemotherapy and Pharmacology. 77, 3, p. 441-457 17 p.Research output: Contribution to journal › Review article › peer-review
137 Citations (Scopus) -
2013
EO9 (Apaziquone): From the clinic to the laboratory and back again
Phillips, R. M., Hendriks, H. R. & Peters, G. J., Jan 2013, In: British Journal of Pharmacology. 168, 1, p. 11-18 8 p.Research output: Contribution to journal › Review article › peer-review
60 Citations (Scopus) -
2007
Tailoring Targeted Therapy to Individual Patients: Lessons to be Learnt from the Development of Mitomycin C
Volpato, M. & Phillips, R. M., May 2007, In: Cancer Genomics and Proteomics. 4, 3, p. 175-186 12 p.Research output: Contribution to journal › Review article › peer-review
9 Citations (Scopus) -
2004
Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)
Phillips, R. M. & Basu, S., 1 Mar 2004, In: Current Pharmacogenomics. 2, 1, p. 75-82 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Citations (Scopus) -
1998
Prospects for bioreductive drug development
Phillips, R. M., Jun 1998, In: Expert Opinion on Investigational Drugs. 7, 6, p. 905-928 24 p.Research output: Contribution to journal › Review article › peer-review
11 Citations (Scopus) -
1996
Human DT-diaphorase as a candidate for enzyme-directed bioreductive drug development
Phillips, R. M., Dec 1996, In: Drugs of the Future. 21, 12, p. 1247-1256 10 p.Research output: Contribution to journal › Review article › peer-review
2 Citations (Scopus) -
1994
Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies
Ross, D., Beall, H., Traver, R. D., Siegel, D., Phillips, R. M. & Gibson, N. W., 1994, In: Oncology Research. 6, 10-11, p. 493-500 8 p.Research output: Contribution to journal › Review article › peer-review
106 Citations (Scopus) -
1990
A Critical Appraisal of the Predictive Value of In Vitro Chemosensitivity Assays
Phillips, R. M., Bibby, M. C. & Double, J. A., 19 Sep 1990, In: Journal of the National Cancer Institute. 82, 18, p. 1457-1468 12 p.Research output: Contribution to journal › Review article › peer-review
99 Citations (Scopus)